Evidence map›Paper›PMID 26669662›Full record

ArticleEuropean journal of human genetics : EJHG2016

Genes for spinocerebellar ataxia with blindness and deafness (SCABD/SCAR3, MIM# 271250 and SCABD2).

Claire Guissart, Nathalie Drouot, Ibrahim Oncel, Bruno Leheup, Ruth Gershoni-Barush, Jean Muller, Sacha Ferdinandusse, Lise Larrieu, Mathieu Anheim, Elif Acar Arslan and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 4 countries.

Claire GuissartEquipe d'Accueil 7402, Institut Universitaire de Recherche Clinique, Université de Montpellier, Montpellier, France.ORCID 0000-0002-3944-5715
Nathalie DrouotInstitut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), INSERM-U964/CNRS-UMR7104/Université de Strasbourg, Illkirch, France.
Ibrahim OncelDepartment of Pediatrics, Hacettepe University, Ankara, Turkey.
Bruno LeheupCHU de Nancy Pôle Enfants Service de Médecine Infantile et Génétique Clinique, Centre de Référence Syndrome Malformatif et Anomalies du Développement, Vandoeuvre, France.
Ruth Gershoni-BarushRambam Medical Center, Technion Israel Institute of Technology, Haifa, Israel.
Jean MullerLaboratoire de Diagnostic Génétique, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.ORCID 0000-0002-7682-559X
Sacha FerdinandusseLaboratory Genetic Metabolic Diseases, Academic Medical Center, Amsterdam, The Netherlands.
Lise LarrieuLaboratoire de Génétique Moléculaire, CHU de Montpellier, Montpellier, France.
Mathieu AnheimInstitut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), INSERM-U964/CNRS-UMR7104/Université de Strasbourg, Illkirch, France.
Elif Acar ArslanDepartment of Pediatrics, Hacettepe University, Ankara, Turkey.
Mireille ClaustresEquipe d'Accueil 7402, Institut Universitaire de Recherche Clinique, Université de Montpellier, Montpellier, France.
Christine TranchantInstitut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), INSERM-U964/CNRS-UMR7104/Université de Strasbourg, Illkirch, France.
Haluk TopalogluDepartment of Pediatrics, Hacettepe University, Ankara, Turkey.
Michel KoenigEquipe d'Accueil 7402, Institut Universitaire de Recherche Clinique, Université de Montpellier, Montpellier, France.
Institut de Génétique Moléculaire de Montpellier · FRCentre National de la Recherche Scientifique · FRHacettepe University · TRAmsterdam UMC Location University of Amsterdam · NLInserm · FRNutrition-Génétique et Exposition aux Risques EnvironnementauxTechnion – Israel Institute of Technology · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ataxia is a symptom that is often associated with syndromic inherited diseases. We previously reported the linkage of a novel syndrome, ataxia with blindness and deafness (SCAR3/SCABD, OMIM# 271250), to chromosome 6p21-p23 by linkage mapping of an Arab Israeli consanguineous family. We have now identified by whole-exome sequencing a homozygous missense mutation in the Arab Israeli family in the SLC52A2 gene located in 8qter, therefore excluding linkage of this family to 6p. We confirmed the involvement of SLC52A2 by the identification of a second mutation in an independent family with an identical syndromic presentation, which we suggest to name SCABD2. SCABD2 is therefore allelic to Brown-Vialleto-Van Laere syndrome type 2 defined by prominent motoneuronopathy and deafness, and also caused by SLC52A2 mutations. In the course of this project, we identified a clinically similar family with a homozygous missense mutation in PEX6, which is located in 6p21. Therefore, despite false linkage in the initial family, SCABD1/SCAR3 is located in 6p21 and is caused by PEX6 mutations. Both SLC52A2 and PEX6 should be included in screening panels for the diagnosis of syndromic inherited ataxias, particularly as patients with mutations in SLC52A2 can be ameliorated by riboflavin supplementation.

Indexed as

Mutation, MissenseAdenosine TriphosphatasesAdolescentAdultATPases Associated with Diverse Cellular ActivitiesBlindnessCells, CulturedChildDeafnessExomeFemaleHumansMalePedigreeReceptors, G-Protein-CoupledSpinocerebellar AtaxiasAdenosine TriphosphatasesATPases Associated with Diverse Cellular ActivitiesPEX6 protein, humanReceptors, G-Protein-CoupledSLC52A2 protein, humanWASF3 protein, humanWiskott-Aldrich Syndrome Protein Family

Identifiers

PMID26669662
PMCPMC4970675
OpenAlexW2213390996

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.